Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) https://validator.w3.org/feed/docs/rss2.html Enhancing Innate and Adaptive Immunity to Combat Multiple Myeloma: Combined Use of Trispecific NK Cell Engagers (TriKEs) and Bispecific T-Cell Engagers (BiTEs) in Immunotherapy Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) On-demand GLUT3 expression augments CAR-T cell metabolic fitness and antitumor efficacy in glioblastoma models Our Team Affordable Immunotherapy: Opportunities and Challenges Basic Cancer Immunology for Clinicians Thailand Successfully Hosts Its First WIC APAC Webinar, Drawing Strong Regional Interest in Personalized Cancer Vaccines CAR T-cell Immunometabolism: Insights from Patients Member Contents Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy AP-SciBio 2027 x WIC APAC 2027 & Thai Immunology Annual Meeting TTCI to Participate in WIC-APAC 2026 Personalized Cancer Vaccines – A New Frontier in Thailand’s Fight Against Cancer Cell Therapy for Solid Cancers: Promise or Overpromise? A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement Scientific Meeting: Medical Applications of Gene Editing and Synthetic Biology Technologies Antibody-Drug Conjugates (ADCs): Recent Advances in the Treatment of Solid Tumors TTCI Researchers Present and Collaborate at the 29th Annual Meeting of the Japanese Association of Cancer Immunology CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML TTCI Representative Highlights CAR-T Cell Therapy Roadmap at the 74th JSTMCT Annual Meeting in Yokohama TTCI at a glance Chiang Mai University Team Mahidol University Team NRCT Hosts Seminar on “Thai Cancer Immunotherapy: Collaboration, Regulation, and the Future of Treatment” at MHESI Fair 2025 Thai Immunology Annual Meeting 2026 CAR T-cell therapy for paediatric solid tumours: clinical trial development and preclinical modelling International Collaborator IPOPI | SEAPID | Chulalongkorn | Erasmus MC Meeting 2026 White Paper Government Agencies and Related Announcements IMMUNOLOGY SEMINAR: PEPTIDE CANCER VACCINE EXPERIENCE AT NCI Pediatric Neuro-Oncology Consortium – Chulalongkorn University Research Forum Registration Open: 1st International Scientific Symposium in Hematologic Malignancy (CETH, Chulalongkorn University) Khonkaen University Team University of Wisconsin School of Medicine and Public Health Antitumor activities of chimeric antigen receptor T cells targeting Mucin-1 with self-released anti-PD-1 IgG antibody TTCI Webinar “CAR T-cell Immunometabolism, Insights from Patients” Thammasat University Team Chulalongkorn University Team A multi-center clinical research project to study the Safety and Efficacy of CD19 CAR T-cells in ALL (Acute Lymphoblastic Leukemia) by Academic Hubs Patient Care and Toxicities Management of CAR T-cell in Pediatrics Efficiently targeting folate receptor alpha-positive ovarian cancer by human antibody VH domain-based chimeric antigen receptor (CAR) Enhancing T cell cytotoxicity against lung cancer with an αPD-L1 protein engager and gemcitabine combination therapy Enhancing T cell cytotoxicity in multiple myeloma with bispecific αPD-L1 × αCD3 T cell engager-armed T cells and low-dose bortezomib therapy New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma Researchers Develop Method to Remove Specific Problematic Proteins for Improved Drug Effects Equipment Antitumor activities of chimeric antigen receptor T cells targeting Mucin-1 with self-released anti-PD-1 IgG antibody TTCI Members Receive Research Recognition Awards from Faculty of Sciences, Chiang Mai University Celebrating Excellence in Immunotherapy: Dr. Piriya Luangwattananun Honored as Young Investigator